Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

CLTEF
CLARA TECHNOLOGIES CORP
stock OTC

Inactive
Sep 16, 2020
11.60USD0.000%(0.00)250
Pre-market
0.00USD-100.000%(-11.60)0
After-hours
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
May 18, 2021
01:17AM EDT  Calliditas Therapeutics Q1 Loss Per Share SEK 2.51 Vs Loss SEK 1.65 Last Year   RTTNews
01:12AM EDT  Interim Report Q1, 2021   PR Newswire
Apr 27, 2021
08:42AM EDT  Calliditas Therapeutics' 2020 Annual Report Published   PR Newswire
Apr 26, 2021
06:30AM EDT  Notice of annual general meeting of Calliditas Therapeutics AB (publ)   PR Newswire
Apr 23, 2021
04:55AM EDT  Calliditas Therapeutics: EMA Grants Accelerated Assessment Procedure For Nefecon For IgA Nephropathy   RTTNews
02:56AM EDT  EMA Grants Accelerated Assessment Procedure for Nefecon for the Treatment of   PR Newswire
Mar 8, 2021
02:54AM EST  Calliditas strengthens its US Commercial and Medical Affairs Organization   PR Newswire
Jan 18, 2021
02:41AM EST  Genkyotex Announces Positive Phase 1 Data In In High-dose Setanaxib Trial   RTTNews
02:12AM EST  Positive Phase 1 results in high-dose setanaxib trial   PR Newswire
Nov 12, 2020
01:33AM EST  Interim Report Q3, 2020   PR Newswire
Nov 3, 2020
09:25AM EST  Calliditas closes acquisition of a controlling interest in Genkyotex SA   PR Newswire
Oct 1, 2020
04:01AM EDT  The 200th patient's last visit completed in Part A of NefIgArd supporting   PR Newswire
Sep 8, 2020
02:48AM EDT  Calliditas Therapeutics Says First Patient In China Enrolled In Clinical Phase 3 Study NefIgArd With Nefecon   RTTNews
02:12AM EDT  First patient in China enrolled in clinical phase 3 study NefIgArd with lead   PR Newswire
Aug 25, 2020
02:21AM EDT  Calliditas appoints Group General Counsel   PR Newswire
Aug 13, 2020
01:37AM EDT  Calliditas Therapeutics: Interim Report Q2, 2020   PR Newswire
Aug 11, 2020
08:17AM EDT  Calliditas Therapeutics to host conference call to provide Business Update and   PR Newswire
Jul 31, 2020
06:25AM EDT  Number of shares and votes in Calliditas Therapeutics   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC